About to SBAID 2026
SBAID 2026 will be held in Tianjin. Tianjin, as an important biopharmaceutical industry base in the north, has unique advantages in the fields of synthetic biology and intelligent pharmaceuticals. The conference focuses on enabling technologies in synthetic biology, artificial intelligence drug discovery, and innovative drug development, covering cutting-edge directions such as gene circuit design, cell factory construction, and machine learning molecular design. The attending experts will delve into core topics such as cell-free synthesis systems, AI assisted target prediction, generative molecular design, and clinical trial optimization. The conference aims to promote the deep intersection of engineering, computer science, and pharmacology, accelerate the process of new drug development, and contribute innovative strength to global public health.
IMPORTANT DATES
2026-08-28-Submission Deadline
2026-09-05-Registration Deadline
2026-09-12-Conference Date
About a week after the submission-Notification Date
RECORD
All full paper submissions to the SBAID 2026 could be written in English and will be sent to at least two reviewers and evaluated based on originality, technical or research content or depth, correctness, relevance to conference, contributions, and readability. All accepted papers of SBAID 2026 will be published in the conference proceedings, which will be submitted to EI Compendex, Scopus for indexing.
Paper template
Please refer to the paper template for layout
Click to download
Register
All attendees must register in advance to attend the meeting
Consulting service
Submit
Please submit the full text/abstract of the paper to us through the electronic submission system
View more
Call For Papers
Direction 1: Synthetic Biology Synthetic Biology Gene circuit design Cell factory construction Cell-free synthesis system DNA data storage Synthetic genomics Biosensor Design Metabolic Engineering Optimization Synthetic Biosafety Biological Casting Technology Direction 2: Artificial Intelligence Artificial Intelligence Machine learning drug discovery Deep Learning Molecular Design AI assisted target prediction Generative AI Chemistry AI drug repositioning Knowledge Graph Drug Development AI Clinical Trial Design Intelligent drug screening AI pharmaceutical ethics
......
Indexing Service
Technical Sponsor
Call for Reviewers
As a platform for global academic communication, the quality of conference publication has always an aspect attracting much of our attention. To ensure quality of our publication and to better serve the peers in academic circle, we now call for reviewers among professionals and experts of the world. Professionals and experts who hold PhD (doctoral) degree in the conference related areas are encouraged to join in us and together, we will work hard to become a world-class academic conference. Please send us your CV by email (sbaid@confsflow.com) if you are interested in it.
SCI Journal
Contributors are encouraged to submit papers / abstracts to the conference. The organizing committee will select high-quality papers and recommend them to SCI/SSCI journals. For specific matters, please contact the person in charge of the conferrence.
Submission Guidelines
Delegates are encouraged to submit their papers/abstracts to the conference. Good quality papers will be selected by the organizing committee and Prof. Soteris Kalogirou, the editor in chief. After it, the authors will be invited to extent their papers/abstracts and submit them to sbaid@confsflow.com. The normal size of research papers is 4,000-6,000 words excluding abstract and references.
Submission Portal
If you have any questions or need any help about the conference, please feel free to contact our conference experts on the right:
杨老师
TEL:185 8288 1690
QQ:3965998409
E-mail:sbaid@confsflow.com
About Plagiarism Check
Crosscheck Powered by iThenticate will be used for plagiarism check. The amount of duplication from previously published content should be less than 20%; If the amount of duplication is 20% - 35%, modification maybe required; if the amount of duplication exceeds 35%, the article will be rejected. Please note that there will be no refund for no-shows.